American Registry of Pathology Press
AFIP Fascicles: The heart of your medical libraryHistory of AFIP/ARP Fascicles
The Atlas of Tumor Pathology has a long and distinguished history. It was first conceived at a cancer research meeting held in St. Louis in September 1947, as an attempt to standardize the nomenclature of neoplastic diseases. The first series was sponsored by the National Academy of Sciences-National Research Council. Many of the illustrations were provided by the Armed Forces Institute of Pathology (AFIP), which was also the organization responsible for the final printing. The American Registry of Pathology (ARP) purchased the Fascicles from the Government Printing Office and sold them virtually at cost.
Over a period of 20 years, approximately 15,000 copies each of nearly 40 Fascicles were produced. The worldwide impact of these publications over the years has surpassed the original goal. They quickly became among the most influential publications on tumor pathology, primarily because of their high quality, but also because their low cost made them easily accessible to pathologists and other students of oncology.
Upon completion of the first series, the National Academy of Sciences-National Research Council handed further pursuit of the project over to the newly created Universities Associated for Research and Education in Pathology (UAREP). Once the second series was completed, with a success that matched that of the first, ARP, UAREP and AFIP decided to embark on a third series.With UAREP and AFIP no longer functioning, ARP is now the responsible organization. New features include a hardbound cover and illustrations almost exclusively in color. Also, there is an increased emphasis on the cytopathologic and molecular features that are important in diagnosis and prognosis. What does not change from the previous series, however, is the goal of providing the practicing pathologist with thorough, concise and up-to-date information on the nomenclature and classification; epidemiologic, clinical, and pathogenetic features; and, most importantly, guidance in the diagnosis of the tumors and tumor-like lesions of all major organ systems and body sites. In addition, as in the third series, a continuous attempt is made to correlate the nomenclature used in the Fascicles with that proposed by the World Health Organization’s Classification of Tumors. The ongoing efforts of the editor-in-chief, associate editors, Editorial Advisory Board, the reviewers, the editorial and production staff, and the individual Fascicle authors ensure that this series is a worthy successor to the previous three.